Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Preclinical information counsel HT-KIT could provide a safer, focused possibility for uncommon KIT-driven cancers like GIST and leukemia by silencing the KIT gene.Preclinical...
A trial is investigating ATR-04 to deal with EGFR inhibitor-related rashes in lung most cancers.The section 1/2 ATR04-484 medical trial is analyzing ATR-04...
After surviving prostate most cancers, Andy Winnegar acquired a analysis of persistent lymphocytic leukemia (CLL) in 2021. Make amends for Andy's blogs right here!In...
